Skip to main content
. Author manuscript; available in PMC: 2017 Mar 15.
Published in final edited form as: J Immunol. 2016 Feb 5;196(6):2591–2601. doi: 10.4049/jimmunol.1501120

Figure 1. Generation of mice with conditional deletion of relb or nfkb2 in B-cells and simultaneous expression of eGFP.

Figure 1

(A and D) Targeting strategy showing the status of relb and nfkb2 before (top) and after (bottom) Cre-mediated recombination. Numbers indicate the respective exons. (B and E) Western blot analysis of RELB and p52 protein levels in purified splenic B cells of the indicated genotypes, and (C) of flow-sorted eGFP+ B-cells from relbfl/flCD19-Cre mice and the corresponding eGFP+ relfl/+CD19-Cre and eGFP− CD19-Cre control mice.